International Clinical Trial: Predicting the Efficacy of Lenvatinib Combined with Immunotherapy and Interventional Therapy for Unresectable Hepatocellular Carcinoma Using Multi-Sequence MRI Machine Learning Model: A Multicenter Study

Geneva, April 20 -- International Clinical Trials Registry received information related to the study (ChiCTR2600121791) titled 'Predicting the Efficacy of Lenvatinib Combined with Immunotherapy and Interventional Therapy for Unresectable Hepatocellular Carcinoma Using Multi-Sequence MRI Machine Learning Model: A Multicenter Study' on April 2.

Study Type: Diagnostic test

Study Design: Diagnostic test for accuracy

Primary Sponsor: Sun Yat-sen Memorial Hospital, Sun Yat-sen University

Condition: primary hepatocellular carcinoma

Intervention: Gold Standard:Pathological examination

Recruitment Status: Recruiting

Phase: Retrospective study

Date of First Enrollment: 2026-04-02

Target Sample Size: Target condition:400;Difficult con...